COMMUNIQUÉS West-GlobeNewswire
-
STERIS Announces Financial Results for Fiscal 2026 Second Quarter
05/11/2025 -
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
05/11/2025 -
PharmaCorp Announces C$15 Million Bought Deal Public Offering
05/11/2025 -
SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update
05/11/2025 -
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
05/11/2025 -
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
05/11/2025 -
Dyne Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
05/11/2025 -
The Pennant Group Announces Expansion of Credit Facility
05/11/2025 -
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
05/11/2025 -
New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System
05/11/2025 -
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
05/11/2025 -
BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
05/11/2025 -
FDA Warns Companies Over Illegal Marketing of Botox and Related Products
05/11/2025 -
Emerald Heights Social Accountability Committee Donates $305,000 to Support 15 Charities Benefiting Local Communities
05/11/2025 -
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
05/11/2025 -
UPDATE - MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
05/11/2025 -
VALNEVA Déclaration d’actions et de droits de vote : 31 octobre 2025
05/11/2025 -
VALNEVA Declaration of shares and voting rights: October 31, 2025
05/11/2025 -
beyond|AESTHETICS Celebrates 10 Years of Excellence with Grand Holiday Event
05/11/2025
Pages